S043 The Quality Improvement and Innovation Symposium
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
The QI Symposium will feature of panel of clinical trialists in dermatology who will provide a framework for incorporating QI into daily practice to improve recruitment and retention of diverse patient populations in clinical trials. The symposium will also feature the AAD's Resident Quality Improvement Award and Innovations in Quality Improvement Award Recipients.
This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuing Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Develop plans to improve recruitment and retention of a diverse patient population in clinical trials and clinical research in dermatology.
Recognize areas of opportunity to implement quality improvement methods or models to improve clinical or clinical research practice outcomes
Discuss ways in which quality improvement can be integrated into clinical care or research practices across various settings, such as private practice, industry, and academic practice.
SCHEDULE
5:00 PM
Strategies for Recruitment of a Diverse Patient Population for Dermatology Clinical Trials (Panel Discussion)
Martina J Porter, MD, FAAD, Theodore J. Alkousakis, MD, FAAD, Chesahna Kindred, MD, MBA, FAAD, Leon H. Kircik, MD, FAAD
6:15 PM
Improving Patient Access and Care through the Development and Implementation of a Rapid-access Clinic
Thy Nhat Huynh, MD, FAAD
6:40 PM
Improving equitable access to UMass Dermatology.
Tracey Otto, MS, MD, Gabriella Paquette, MD
6:52 PM
Implementation of a quality improvement project to increase referral rates for genetic counseling and testing in patients with melanoma.
Caroline Starling, MD
7:04 PM
Picture This: Using Dermoscopy Photos to Expedite Dermatology Access.
Ariel Park, MD
7:16 PM
The OHSU Dermatology No-Show Standby List Pilot Program.
Riyad Seervai, PhD, MD
7:28 PM
Management of Patients with Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis at MetroHealth Medical Center.
Andrew Tran, MD, Sarah Williamson, MD
7:40 PM
Patient-centered education initiatives to improve health literacy and safe use of medications in outpatient pediatric dermatology.
Grace Wei, MD
SPEAKERS
Theodore J. Alkousakis, MD, FAAD
Ramona Behshad, MD, FAAD
Thy Nhat Huynh, MD, FAAD
Chesahna Kindred, MD, MBA, FAAD
Leon H. Kircik, MD, FAAD
John O'Malley, MD, PhD, FAAD
Tracey Otto, MS, MD
Gabriella Paquette, MD
Ariel Park, MD
Martina J Porter, MD, FAAD
Riyad Seervai, PhD, MD
Caroline Starling, MD
Andrew Tran, MD
Grace Wei, MD
Sarah Williamson, MD
HANDOUTS
SPEAKER DISCLOSURES
Theodore J. Alkousakis, MD, FAAD
Eli Lilly – Stockholder Public Company(No Compensation Received); Johnson & Johnson Innovative Medicine – Employee (w-2 relationship)(Salary), Employee (w-2 relationship)(Stock), Employee (w-2 relationship)(Stock Options);
Ramona Behshad, MD, FAAD
Castle Biosciences, Inc – Investigator(Grants/Research Funding);
Thy Nhat Huynh, MD, FAAD
No financial relationships exist with ineligible companies.
Chesahna Kindred, MD, MBA, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Speaker(Fees); Aerolase – Speaker(Fees); Arcutis Biotherapeutics – Speaker(Fees); Eli Lilly – Investigator(Fees); Factor Medical – Speaker(Fees); Lilly ICOS LLC – Advisory Board(Fees), Speaker/Faculty Education(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Nutrafol – Speaker/Faculty Education(Fees); Pfizer Inc. – Speaker/Faculty Education(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); UCB – Advisory Board(Fees); Xtresse – Stockholder Private Company(No Compensation Received);
Leon H. Kircik, MD, FAAD
3M Pharmaceuticals – Investigator(Grants/Research Funding), Speaker(Honoraria); Abbott Laboratories – Speaker(Honoraria); Ablynx – Investigator(Grants/Research Funding); Acambis – Investigator(Grants/Research Funding); Allergan, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Honoraria), Speaker(Honoraria); Almirall – Consultant(Honoraria); Alumis – Advisory Board(Honoraria); Amgen – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); AnaptysBio – Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Apollo Therapeutics Ltd – Investigator(Grants/Research Funding); Aqua – Advisory Board(Honoraria); Arcutis, Inc. – Investigator(Grants/Research Funding); Astellas Pharma US, Inc – Investigator(Grants/Research Funding), Speaker(Honoraria); Asubio Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Bayer Consumer Healthcare Pharmaceuticals – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Biofrontera – Consultant (1099 relationship)(Honoraria); Biogen – Advisory Board(Honoraria); Biolife – Investigator(Grants/Research Funding); Biopelle, Inc. – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Botanix Pharmaceuticals – Consultant(Honoraria); Breckinridge Pharma – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Cassiopea SpA – Consultant(Honoraria); Celgene – Consultant(Honoraria), Investigator(Grants/Research Funding); Cellceutix – Investigator(Grants/Research Funding); Centocor Ortho Biotech Inc. – Investigator(Grants/Research Funding); ChemoCentryx – Investigator(Grants/Research Funding); ColBar LifeScience Ltd. – Advisory Board(Honoraria), Consultant(Honoraria); CollaGenex Pharmaceuticals, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Connetics Corporation – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Coria Laboratories – Investigator(Grants/Research Funding); Dermata Therapeutics – Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Dermik Laboratories, a business of sanofi-aventis U.S. LLC – Speaker(Honoraria); Dow Pharmaceutical Sciences, Inc. – Investigator(Grants/Research Funding); DUSA Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Embil Pharmaceuticals, Co., Ltd – Speaker(Honoraria); Enveda Biosciences – Investigator(Grants/Research Funding); EOS – Advisory Board(Honoraria); Feldan Therapeutics – Consultant (1099 relationship)(Honoraria); Ferndale Laboratories, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Genentech, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); GlaxoSmithKline – Investigator(Grants/Research Funding); Healthpoint – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); Intendis, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Isdin – Advisory Board(Honoraria); Johnson & Johnson Consumer Products Company – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria), Stockholder(Stock); Kymera Therapeutics – Advisory Board(Honoraria); L'Oreal – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Laboratory Skin Care, Inc. – Consultant(Honoraria); Leo Pharma Inc – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); MC2 Therapeutics – Consultant(Honoraria); Medical International Technologies – Consultant(Honoraria); Medicis Pharmaceutical Corporation – Investigator(Grants/Research Funding); Merck – Investigator(Grants/Research Funding); Merck & Co., Inc – Consultant(Honoraria); Merck Serono – Speaker(Honoraria); Merz Pharmaceuticals, LLC – Consultant(Honoraria); NanoBio Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Nucryst – Investigator(Grants/Research Funding); Obagi Medical Products – Investigator(Grants/Research Funding); Onset Dermatologics – Investigator(Grants/Research Funding), Speaker(Honoraria); Organon Biosciences SRL – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pharmaderm – Investigator(Grants/Research Funding), Speaker(Honoraria); Promius Pharma, LLC – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); PuraCap Pharmaceutical – Consultant(Honoraria); QLT Inc. – Investigator(Honoraria); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sagimet Biosciences – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Sandoz, a Novartis company – Investigator(Grants/Research Funding); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); SkinMedica, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Stiefel a GSK company – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Taro Pharm – Consultant(Honoraria), Investigator(Grants/Research Funding); TolerRx – Investigator(Grants/Research Funding); Triax Pharmaceuticals, LLC – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); UCB Pharma – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Valeant Pharmaceuticals International – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Vellera – Stockholder Private Company(No Compensation Received); Warner Chilcott – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Xenoport, Inc. – Investigator(Grants/Research Funding); Zalicus – Investigator(Grants/Research Funding);
John O'Malley, MD, PhD, FAAD
Sanofi Genzyme – Employee(Salary);
Tracey Otto, MS, MD
No financial relationships exist with ineligible companies.
Gabriella Paquette, MD
No financial relationships exist with ineligible companies.
Ariel Park, MD
No financial relationships exist with ineligible companies.
Martina J Porter, MD, FAAD
AbbVie – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Alumis – Consultant(Fees); AnaptysBio – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Bayer – Investigator(Grants/Research Funding); Beth Israel Deaconess Medical Center – Other(Patent royalties or other compensation for Intellectual Property Rights); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(No Compensation Received); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant (1099 relationship)(Fees); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Consultant(Fees); Merck – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Mirador – Investigator(Grants/Research Funding); Moonlake – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Navigator Medicines – Consultant (1099 relationship)(Fees); Novartis – Consultant(Fees), Investigator(Grants/Research Funding); Oasis Pharmaceuticals – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Prometheus Laboratories, Inc. – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sonoma Biotherapeutics – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Trifecta Clinical – Consultant(Fees); UCB – Consultant(Fees), Investigator(Grants/Research Funding); Zura Bio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding);
Riyad Seervai, PhD, MD
American Academy of Dermatology – Other(Grants/Research Funding); American Society of Dermatopathology – Other(Grants/Research Funding); European Academy of Dermatology and Venereology – Other(Grants/Research Funding); Oregon Dermatology Society – Other(Grants/Research Funding); Sanova Works – Advisory Board(Honoraria);
Caroline Starling, MD
No financial relationships exist with ineligible companies.
Andrew Tran, MD
No financial relationships exist with ineligible companies.
Grace Wei, MD
No financial relationships exist with ineligible companies.
Sarah Williamson, MD
No financial relationships exist with ineligible companies.